{
    "Trade/Device Name(s)": [
        "Dropper A1c Diabetes Control",
        "Dropper\u2122 A1c Diabetes Control"
    ],
    "Submitter Information": "Quantimetrix Corporation",
    "510(k) Number": "K103744",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "December 17, 2010",
    "Summary Letter Received Date": "March 7, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Quantimetrix Dropper A1c Diabetes Control intended as a quality control material for laboratory HbA1c quantitation procedures",
    "Indications for Use Summary": "Intended for the quality control of laboratory procedures used to quantitate HbA1c",
    "fda_folder": "Clinical Chemistry"
}